Chronic liver disease frequently remains undetected until fibrosis, cirrhosis, or other complications have developed, in part because patients may have no symptoms during earlier stages. This places primary care clinicians in a critical position to identify risk factors, investigate abnormal laboratory or imaging findings, and initiate screening before advanced disease is present.
In the following Q&A, Stevan Gonzalez, MD, MS, director of Liver Transplantation at Baylor Scott & White All Saints Medical Center in Fort Worth, Texas, discusses the populations most likely to be missed, practical opportunities for earlier detection, and why identifying liver disease before symptoms develop can substantially alter its course.
[…]